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signals
Karolina Punovuori1, Rosa P. Migueles1, Mattias Malaguti1, Guillaume Blin1, Kenneth G. Macleod2,
Neil O. Carragher2, Tim Pieters3, Frans van Roy4, Marc P. Stemmler5 and Sally Lowell1,*
ABSTRACT
A switch from E- to N-cadherin regulates the transition from
pluripotency to neural identity, but the mechanism by which
cadherins regulate differentiation was previously unknown. Here, we
show that the acquisition of N-cadherin stabilises neural identity by
dampening anti-neural signals. We use quantitative image analysis to
show that N-cadherin promotes neural differentiation independently of
its effects on cell cohesiveness. We reveal that cadherin switching
diminishes the level of nuclear β-catenin, and that N-cadherin also
dampens FGF activity and consequently stabilises neural fate. Finally,
we compare the timing of cadherin switching and differentiation in vivo
and in vitro, and find that this process becomes dysregulated during
in vitro differentiation.We propose that N-cadherin helps to propagate a
stable neural identity throughout the emerging neuroepithelium, and
that dysregulation of this process contributes to asynchronous
differentiation in culture.
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INTRODUCTION
There is an increasing appreciation that changes in adhesion and
morphology help to regulate cell fate changes (Gilmour et al.,
2017). The homotypic adhesion molecule E-cadherin (also known
as cadherin 1) is expressed on the surface of pluripotent cells and is
downregulated and replaced with N-cadherin (cadherin 2) during
early neural development (Hatta and Takeichi, 1986; Wheelock
et al., 2008). We previously reported that loss of E-cadherin is not
simply a consequence of differentiation, but rather that it actively
promotes the neural differentiation process (Malaguti et al., 2013).
However, the role of N-cadherin in this process and the
mechanisms by which cadherins regulate neural differentiation
are not known.
It has previously been reported that premature cadherin switching
has profound effects at gastrulation, including an expansion of
the extra-embryonic compartment, a reduction in the size of the
epiblast, and mispatterning of the germ layers (Basilicata et al.,
2016). These diverse phenotypes can be attributed, at least in part, to
an overall reduction in BMP signalling within the epiblast and a
reduction in pro-mesoderm signals at the primitive streak, which in
turn may result from the gross morphological defects seen in these
embryos (Basilicata et al., 2016). However, it is not clear which
aspects of this complex phenotype are an indirect consequence of
defects in extra-embryonic tissues and which, if any, are cell-
autonomous. Here, we use cultured mouse pluripotent cells in order
to focus on the mechanism by which cadherin switching influences
neural differentiation of pluripotent cells in the absence of
extra-embryonic tissues.
Mouse pluripotent cells can be cultured in the presence of
inhibitors of MEK and Gsk3β plus LIF (2i-Lif ) in order to maintain
them in a naïve embryonic stem cell (ESC) state equivalent to the
preimplantation epiblast (Boroviak et al., 2015; Ying et al., 2008),
or they can be cultured in the presence of FGF and activin in order to
maintain a differentiation-primed epiblast stem cell (EpiSC) state
equivalent to the postimplantation epiblast (Brons et al., 2007;
Nichols and Smith, 2009; Tesar et al., 2007). LIF and foetal calf
serum (FCS) support a heterogeneous mixture of pluripotent cells
moving in and out of the naïve state. We previously reported that
cells downregulate E-cadherin during neural differentiation of
ESCs, and that loss of E-cadherin leads to faster, more synchronous
neural differentiation in vitro (Malaguti et al., 2013), in keeping
with other reports that E-cadherin acts as a ‘brake’ to slow down
differentiation of pluripotent cells (Chou et al., 2008; del Valle et al.,
2013; Faunes et al., 2013; Livigni et al., 2013; Redmer et al., 2011;
Soncin et al., 2009). E-cadherin-null ESCs display a loss of cell-cell
adhesion (Larue et al., 1994, 1996), raising the possibility that their
neural differentiation phenotype may be a secondary consequence
of their adhesion defect. Alternatively, cadherins could influence
differentiation by modulating signalling independently of adhesion
(Bedzhov et al., 2012; del Valle et al., 2013; Wheelock et al., 2008;
Zhang et al., 2010).
Neural specification depends on inhibition of BMP and Nodal
signalling (Camus et al., 2006; Di-Gregorio et al., 2007). The ability
of BMP to block neural fate is at least in part due to maintenance of
E-cadherin expression, but it is not known which signalling
pathways act downstream of cadherins to modulate differentiation.
Dampening of either FGF (Greber et al., 2010; Jaeger et al., 2011;
Stavridis et al., 2010; Sterneckert et al., 2010) or Wnt (Aubert et al.,
2002; Haegele et al., 2003) has the effect of stabilising neural
identity. N-cadherin has been reported to modulate FGF activity
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2001) and E-cadherin has been reported to modulate Wnt activity in
other contexts (Howard et al., 2011), and so it seems plausible that
cadherin switching may modulate neural differentiation via
dampening of one or both of these anti-neural signalling
pathways. Alternatively, it is possible that cadherins modulate
other signalling pathways (Pieters and van Roy, 2014).
Here, we set out to determine how the switch from E-cadherin to
N-cadherin influences differentiation. We present evidence that
N-cadherin promotes neural differentiation by dampening FGF
activity. We also discover that cadherin switching occurs later and
more synchronously during anterior neural differentiation in vivo
compared with neural differentiation in culture. We suggest that
cadherins could mediate a ‘community effect’ by helping to
propagate differentiation decisions to neighbouring cells, and that
this may help to ensure synchronous neural commitment in the
embryo. This effect partly breaks down in culture, helping to
explain why differentiation in culture is relatively asynchronous
even in the face of a uniform extrinsic environment.
RESULTS
Cadherin switching is initiated prior to the onset of neural
differentiation in vitro
Wepreviously reported that E-cadherin inhibits neural differentiation,
but the mechanism of action was not known (Malaguti et al., 2013).
Upregulation of N-cadherin accompanies the loss of E-cadherin as
pluripotent cells adopt a neural fate (Dady et al., 2012; Hatta and
Takeichi, 1986), raising the possibility that N-cadherin might
contribute to the regulation of the differentiation process. We first
asked when N-cadherin becomes detectable during neural
differentiation (note that we use the phrase ‘neural differentiation’
to mean the transition from pluripotency to neural identity rather than
terminal differentiation into a particular neural derivative).
We confirmed that mouse ESCs cultured in 2i-Lif or Lif-serum
express high levels of E-cadherin, whereas N-cadherin mRNA and
protein were undetectable in either of these culture conditions
(Fig. 1A,B). In EpiSC culture, E-cadherin expression was
heterogeneous whereas N-cadherin became detectable in a
subpopulation of cells (Fig. 1A-C). Cultures of EpiSCs contain
spontaneously differentiating cells, and so we focused only on
undifferentiated (Oct4+; also known as Pou5f1) cells (Fig. 1D,
Fig. S1A). Almost all (99.6%) Oct4+ cells expressed E-cadherin and,
of these, 13.0% also expressed N-cadherin (Fig. 1E). Very few (<1%)
Oct4+ cells expressed N-cadherin alone. These results (Fig. S1) show
that N-cadherin becomes expressed in a subpopulation of E-cadherin+
cells prior to loss of Oct4 expression.
Fluorescence-activated cell sorting (FACS) analysis confirmed that
the vast majority of EpiSCs express E-cadherin, but revealed
considerable cell-to-cell variability in the levels of this adhesion
molecule on the cell surface (Fig. 1C, red curve). This contrasted with
naïve pluripotent cells, which displayed uniformly high levels of
E-cadherin throughout the population (Fig. 1C, blue curve). To
further study cadherin heterogeneity in differentiation-primed cells,
EpiSCs were sorted into three subpopulations (EcadHigh, EcadMed,
and EcadLow) (Fig. 1F,G). EcadHigh and EcadLow populations were
then analysed by qRT-PCR, normalising to the EcadMed population
(Fig. 1H). This analysis revealed a reciprocal expression pattern
between E-cadherin and N-cadherin, consistent with an ongoing
process of cadherin switching (Fig. 1H). The subpopulations
expressed similar levels of the general pluripotency factors Oct4
and Nanog, and the primed pluripotency factor Oct6 (Pou3f1),
indicating no difference in their overt differentiation status (Fig. 1H).
It has been reported that differentiation-primed subpopulations of
undifferentiated EpiSCs express low levels of either the neural-
priming factor Sox1 or the mesoderm-priming factor T (brachyury)
(Tsakiridis et al., 2014). We found that the E-cadLow population
expressed significantly higher levels of Sox1 and T, characteristic of a
differentiation-primed subpopulation, whereas markers of surface
ectoderm (Ap2a; Tfap2a) or endoderm (Sox17) did not differ
significantly between the populations (Fig. 1H).
These results indicate that N-cadherin starts to become detectable
prior to the loss of pluripotency transcription factors, and that a
subpopulation of EpiSCs with lower E-cadherin and higher
N-cadherinmay be primed for neural andmesodermal differentiation.
We next examined cultures at an early stage of neural
differentiation [day (D) 4], when around 50% of cells had started to
adopt a neural identity, as revealed by immunostaining for Sox1-GFP
(Ying et al., 2003), a reporter for the earliest marker of neuroepithelial
identity (Wood and Episkopou, 1999) (Fig. 1I, Fig. S1B). In these
cultures, N-cadherin was detectable in almost all Sox1-GFP+ neural
cells, and of these around half also retained E-cadherin expression. Of
cells that had not yet acquired a Sox1-GFP+ neural identity, almost all
expressed E-cadherin, and of these around 20% also expressed
N-cadherin (Fig. 1J).
Taken together, these results suggest that cadherin switching is
initiated prior to the onset of neural differentiation in vitro.
N-cadherin promotes neural differentiation
Loss of E-cadherin is associated with neural differentiation of
ESCs but the mechanisms by which cadherins might influence
neural differentiation are not known (Malaguti et al., 2013). One
possibility is that this pro-neural differentiation phenotype of cells
lacking E-cadherin function may be a secondary consequence of
their adhesion defect (Larue et al., 1994, 1996). If this is the case,
then restoring adhesion should restore normal neural differentiation
capacity. N-cadherin can rescue the E-cadherin adhesion
phenotype, at least in the context of preimplantation development
(Bedzhov et al., 2012; Kan et al., 2007). We therefore asked whether
providing N-cadherin to E-cadherin-null cells would rescue their
neural differentiation phenotype.
To address this question, we made use of two E-cadherin
knockout ESC lines: Ecad−/−, in which both cadherin alleles have
been knocked out (Pieters et al., 2016), and an N-cadherin knock-in
line, EcadNcad/Ncad, in which the coding sequence of N-cadherin is
knocked into the E-cadherin locus, placing exogenous N-cadherin
under the control of the endogenous E-cadherin regulatory elements
and eliminating E-cadherin expression (Basilicata et al., 2016; Kan
et al., 2007; Libusova et al., 2010) (Fig. 2A). The EcadNcad/Ncad cells
have been previously shown to enforce a cadherin switch while
maintaining cell-cell adhesion in some developmental contexts
(Kan et al., 2007). Because the two lines differ in their genetic
background, they are analysed side-by-side with their relevant
control cell lines. For the E-cadherin cell line, the control is the
parental cell line in which the E-cadherin locus contains the loxP
sites but recombination has not yet taken place (EcadFlox/Flox). For
the E-cadherinNcad/Ncad cells, the wild-type (WT) control is the
parental cell line in which the E-cadherin coding sequence is still
intact (EcadWT/WT).
We confirmed that N-cadherin was expressed above control
levels in EcadNcad/Ncad cells throughout the course of differentiation,
but was not significantly elevated above background levels in
Ecad−/− cells (Fig. 2B).
Both Ecad−/− and EcadNcad/Ncad cells can be maintained in 2i-Lif
conditions. When challenged with neural differentiation conditions,
both cell lines were able to switch on the neural marker genes Sox1,
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Pax6 and Pax3 (Fig. 2B-D) (Pax3 is also expressed in the paraxial
mesoderm, but is unlikely to be marking mesoderm in this context
because the pan-mesodermal marker T is not upregulated above
background levels in this set of experiments; Fig. S2). Ecad−/− cells
displayed a moderate pro-neural phenotype with some variability in
neural gene expression (Fig. 2B-D). However, they showed greater
instability than control cells, with very few cells surviving past d4 of
neural differentiation (Fig. S3). In contrast, EcadNcad/Ncad cells
exhibited a more pronounced pro-neural phenotype, differentiating
more rapidly than control cells (Fig. 2B-D). Quantification of Sox1
expression in individual cells indicated that although Sox1 shows
considerable cell-cell variability in both control and (to a lesser
extent) Ecad−/− populations, this variability was largely eliminated
in EcadNcad/Ncad cells, which exhibited uniformly high Sox1
expression by D3 (Fig. 2C,D). These results indicated that
exogenous N-cadherin reinforces rather than reverses the pro-neural
phenotype of E-cadherin-null cells.
In order to test further whether N-cadherin contributes to
promoting neural differentiation, we designed cell lines that
allowed us to force expression of N-cadherin in the presence of
endogenous E-cadherin. These cells, termed A2Lox-Ncad-HA
cells, are engineered to enable doxycycline (dox)-inducible
Fig. 1. Cadherin switching precedes the loss of pluripotency marker expression and coincides with neural priming in vitro. (A) Cells cultured in three
pluripotent conditions stained for E-cadherin, N-cadherin and the nuclear envelope marker lamin B1. (B) qRT-PCR analysis of E-cadherin and N-cadherin
expression in cells cultured in three pluripotent conditions, n=3. (C) Flow cytometric analysis of E- and N-cadherin expression in cells cultured in various
pluripotent conditions; curves show a representative sample of three biological replicates. (D) Example ICC image of EpiSCs stained for Ecad, Ncad, Oct4 and
lamin B1. (E) Quantification of protein co-expression in EpiSCs. n=2596 cells from three biological replicates. (F) Sorting and analysis strategy for EpiSCs
heterogeneously expressing E-cadherin. (G) Example FACS gating of EpiSCs into three populations based on their level of E-cadherin expression; each
population makes up ∼20% of live cells. (H) qPCR analysis of sorted EpiSC populations. EcadLow and EcadHigh populations were normalised to the EcadMed
population. n=3 independent sorts. (I) Example ICC image of Sox1-GFP (46C) cells undergoing neural differentiation stained for Ecad, Ncad, Sox1 and lamin B1.
(J) Quantification of protein co-expression in Sox1-GFP cells undergoing neural differentiation. n=2275 cells from three biological replicates. Error bars represent
s.d., *P≤0.05, **P≤0.01, paired Student’s t-test. All images shown to same scale. Scale bars: 50 μm.
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Fig. 2. N-cadherin promotes neural differentiation. (A) Cadherin expression in four cell lines used for cadherin domain deletion/substitution experiments.
Cells cultured in neural differentiation conditions for 24 h. Lamin B1: nuclear envelope marker. (B) qPCR analysis of the above cell lines during successive days of
neural differentiation. n=3. Values normalised to control cell line on day (D)0. (C) Representative images showing expression of the early neural marker Sox1 in
above cells after 3-4 days of neural differentiation. (D) Quantification of Sox1 expression in the above cells during neural differentiation. n=9, three fields of view from
three biological replicates. (E) ICC of inducible N-cadherin-overexpressing cells cultured in neural differentiation conditions for 24 h with or without dox. (F) Protocol
for neural differentiation of inducible N-cadherin-overexpressing cells. Triangles indicate sample collection. (G,H) qPCR analysis of inducible N-cadherin-
overexpressing cells during neural differentiation; dox added on day 2. n=9 (three biological replicates of three independent clones). Error bars represent s.d.,
*P≤0.05, **P≤0.01, ***P≤0.001, unpaired Student’s t-test. N.D., not determined. Scale bars: 50 µm.
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expression of an N-cadherin transgene with a C-terminal
HA tag (Fig. 2E).
When exogenous N-cadherin was induced in these cells during
neural differentiation (Fig. 2G), an increase in expression of the
early neural markers Sox1, Pax6 and Pax3, and an accelerated
downregulation of the pluripotency marker Oct4 was observed
(Fig. 2H). E-cadherin was also downregulated more rapidly in the
presence of ectopic N-cadherin, but these differences in E-cadherin
did not emerge until 1 day after the pro-neural phenotype first
became apparent. This might suggest that the loss of E-cadherin is
likely to be a consequence rather than a cause of premature neural
differentiation in these experiments, although we cannot exclude the
possibility that changes in E-cadherin contribute to the effects on
differentiation in these experiments.
Taken together, these results showed that the switch from
E-cadherin to N-cadherin can promote neural differentiation under
permissive conditions, and that the presence of N-cadherin
contributes to this pro-neural effect.
Pro-neural effects of N-cadherin are not explained by
changes in cell cohesiveness
As the primary function of cadherins is in cell-cell adhesion, we
assessed whether the pro-neural effects of cadherin switching might
be a consequence of cells becoming less cohesive, i.e. moving
further apart from one another. In culture, Ecad−/− cells are unable
to form large, compact colonies, instead growing as small dispersed
clumps of a few cells (Fig. 2A) (Larue et al., 1994, 1996). By
contrast, EcadNcad/Ncad cells appear more similar to control cells
(Fig. 2A) in keeping with the ability of N-cadherin to rescue the
adhesion phenotype of E-cadherin-null blastocysts (Bedzhov et al.,
2012; Kan et al., 2007). However, this does not exclude the
possibility that manipulation of N-cadherin expression had subtle
effects on cell cohesion that were not discernible by eye nor did it
exclude the possibility that adhesion or migration defects became
apparent under differentiation conditions.
We set out to measure whether our manipulations of cadherin
expression resulted in changes in cell cohesiveness. We measured
the inter-nuclear distances of cells (Fig. 3A) because we are able to
perform nuclear segmentation with high accuracy (Blin et al., 2019),
and because pluripotent and early neural cells have very scant
cytoplasm, so inter-nuclear distance is a reasonable proxy for inter-
cellular distance. This assay was designed to capture indirectly the
consequences of any changes in adhesion or morphology, which
could include a relaxation of cell-cell contacts, an increase in cell
spreading or cell volume, or an increase in migration. These
measurements were performed in cells that had been cultured in
Fig. 3. Effects of cadherin switching on cellular clustering. (A) Methodology for measuring inter-nuclear edge distances. For each nucleus (white solid line),
the nearest neighbours (grey solid line) within a 40 µm radius (white dotted line) are determined by Delaunay triangulation, and the inter-nuclear edge
distances between these nuclei are calculated; the process is repeated for all nuclei in the image. (B) ICC of all cell lines used for cadherin domain deletion/
substitution experiments stained for lamin B1. Ncad overexpression was performed in A2Lox-Ncad-HA cells. Cells cultured in neural differentiation conditions for
24 h. (C) Density plots of inter-nuclear edge distance in four cell lines. n=1054 for all samples; plots show a representative sample for three biological
replicates. (D) Mean inter-nuclear edge distances. n=3 biological replicates, each containing hundreds to thousands of cells. (E) Mean cell number. n=3 biological
replicates. Error bars represent s.d., *P≤0.05, paired Student’s t-test. Scale bars: 50 μm.
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neural differentiation conditions for 24 h; at this time, cells are
starting to initiate differentiation but have not yet committed to a
neural fate (Kalkan and Smith, 2014).
We demonstrated that Ecad−/− cells had significantly greater mean
inter-nuclear edge distances than control cells at 24 h under
differentiation conditions (Fig. 3B-D), consistent with their
previously reported adhesion defect (Larue et al., 1994, 1996).
Surprisingly, EcadNcad/Ncad cells also had higher mean inter-nuclear
edge distances from one another compared with control cells under
these conditions (Fig. 3C,D). The number of cells present in each
analysis did not differ significantly between the control and
experimental conditions, suggesting that the observed differences in
clustering were not a result of variable cell density (Fig. 3E). These
results indicate that, although N-cadherin can rescue the adhesion
defect of Ecad−/− cells in the context of preimplantation development
(Kan et al., 2007), it cannot fully rescue effects on intercellular
distances (whichmay result from changes in adhesion, migration and/
or morphology) at early stages of neural differentiation in culture.
These observations therefore do not exclude the possibility that the
loss of E-cadherin influences differentiation partly though changes in
adhesion, migration or morphology.
Exogenous N-cadherin can promote neural differentiation even in
the presence of E-cadherin (Fig. 2G), and so we next asked whether
these pro-neural effects of N-cadherin correlate with a change in
inter-nuclear distances. When we induced N-cadherin in the
presence of endogenous E-cadherin, inter-nuclear distances were
barely affected (Fig. 3D). This alerted us to the possibility that the
pro-neural effect of N-cadherin might not be fully explained by
changes in cell cohesiveness, and prompted us to explore whether
other mechanisms may operate.
Loss of E-cadherin leads to the loss of global and nuclear
β-catenin, but does not abolish Wnt responsiveness
If N-cadherin does not promote differentiation entirely through
changes in cell cohesiveness, could it also be modulating pro-neural
or anti-neural signalling pathways? This seems plausible because
cadherins can bind various cell-surface signalling receptors
and modulate signalling in other contexts (Bedzhov et al., 2012;
Fedor-Chaiken et al., 2003; Greber et al., 2010).
We used a reverse phase protein array (RPPA) to measure the
activity of a panel of signalling pathways (Table S2) and asked
which of them are changed in response to cadherin switching. We
assayed signalling pathway activity by measuring changes in the
abundance of total protein levels and various phospho-protein
species in Ecad−/− cells and EcadNcad/Ncad cells compared with their
respective control cell lines. All cell lines were cultured in neural
differentiation conditions for 24 h, a time prior to the emergence of
the earliest neural cells that appear in response to either endogenous
or experimentally induced cadherin switching.
We first confirmed that the most significant change in protein
abundance in Ecad−/− and EcadNcad/Ncad cells was a loss of
E-cadherin, as expected. The next most significant change was a
depletion of β-catenin, levels of which were reduced by 3-fold
both in Ecad−/− and EcadNcad/Ncad cells compared with control
cells (Fig. 4A). This is in keeping with reports that β-catenin
expression is reduced in response to a reduction in E-cadherin in
other contexts (Hendriksen et al., 2008; Van De Wetering et al.,
2001). Ecad−/− cells also have moderately reduced levels of PKA,
AktP-Ser473 and AktP-Thr308, but in all cases levels of these
proteins were restored to at least normal levels in EcadNcad/Ncad
cells, making it unlikely that the pro-neural phenotype could be
attributed to these changes in this context. We therefore focused
on β-catenin as a candidate for mediating the pro-neural effects of
cadherin switching.
As β-catenin is a central player in the canonical Wnt signalling
pathway (Clevers, 2006), and Wnt is an anti-neural signal (Aubert
et al., 2002; Haegele et al., 2003), we assessed whether the reduced
levels of β-catenin caused changes in Wnt signalling responsiveness
during differentiation. We first measured nuclear accumulation of an
unphosphorylated (transcriptionally active) form of β-catenin in
response to Wnt3a (Clevers, 2006). Ecad−/−, EcadNcad/Ncad and
control cells were cultured for 24 h in serum-free media with varying
concentrations of Wnt3a, and the amount of unphosphorylated
β-catenin staining in the nucleus was then quantified. As expected,
nuclear β-catenin increased in control cells in response to increasing
concentrations of Wnt3a (Fig. 4B-D). Strikingly, Ecad−/− and
EcadNcad/Ncad cells accumulated significantly less nuclear β-catenin
compared with WT cells even at the highest dose of Wnt3a. These
results show that Ecad−/− cells display a dampened response to
Wnt3a (at least at the level of β-catenin accumulation), and that this is
not rescued by N-cadherin.
We next asked whether cadherin switching allowed cells to resist
the anti-neural effects of Wnt signalling. We first confirmed that the
addition of Wnt3a suppressed neural differentiation in both WT
cells and Ecad−/− cells, as previously reported (Aubert et al., 2002;
Haegele et al., 2003) (Fig. 4E,F). In contrast, EcadNcad/Ncad cells
upregulated early neural markers even in the presence of high
concentrations of Wnt3a, in keeping with the hypothesis that
cadherin switching maintains neural potency by dampening Wnt
signalling (Fig. 4E,F, Fig. S4).
However, to our surprise, the Wnt target genes Axin2 and T
responded to Wnt3a in EcadNcad/Ncad cells to a similar extent as
control cell lines (Fig. 4G). This indicated that, despite differences
in global and nuclear levels of β-catenin, cells lacking E-cadherin
were able to activate Wnt target genes normally during neural
differentiation, as has been reported to be the case in other contexts
(Van De Wetering et al., 2001). We speculate that this could be
explained if the reduced levels of nuclear β-catenin remain above the
threshold required for an efficient transcriptional response.
It is particularly interesting that EcadNcad/Ncad cells activated the
neural marker Sox1 even in the presence of the anti-neural signal
Wnt3a (Fig. 4E,F); this observation suggests that cadherins become
particularly important for reinforcing differentiation in a suboptimal
signalling environment. However, this pro-neural effect of cadherin
switching did not seem to be explained by a dampening of Wnt
responsiveness because the transcriptional response to Wnt
remained intact.
Cadherin switching dampens FGF signalling during neural
differentiation
We next set out to determine which other signalling pathways are
influenced by cadherin switching. Our RPPA assay indicated that a
large number of proteins involved in signalling pathways were
modulated in response to the concerted loss of E-cadherin and gain
of N-cadherin (Fig. 4A). We previously established that exogenous
N-cadherin reinforces neural differentiation (Figs 2D and 4F), and
so in order to simplify our search we decided to focus on signalling
pathways than are modulated by N-cadherin.
We used a Nanostring assay to focus on transcriptional readouts
of a broad range of signalling pathways. We measured changes in
signalling pathway activity 48 h after inducing N-cadherin
expression during neural differentiation using our dox-inducible
N-cadherin cell line (A2Lox-Ncad-HA) as this was the time point at
which the pro-neural phenotype became clearly apparent.
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Fig. 4. Effects of cadherin switching on β-catenin and Wnt signalling. (A) Heat map showing enrichment of protein and phospho-protein species in Ecad−/−
and EcadNcad/Ncad cells compared with control cell lines; all cells were cultured in neural differentiation conditions for 24 h at time of analysis. Data generated by
RPPA, n=3. (B) Example confocal images of cells at 24 h of neural differentiation cultured in varying Wnt3a concentration and stained for unphosphorylated
β-catenin. (C) Quantitative visualisations of nuclear staining of the images shown in B. (D) Quantification of mean nuclear voxel intensity for unphosphorylated
β-catenin in cells cultured for 24 h in neural differentiation conditions. n=4 biological replicates, each containing hundreds of cells. (E,F) Example images (E) of
Sox1 expression in cells cultured with or without Wnt3a. ‘High Wnt3a’ refers to 100 ng/ml. Dot plots (F) show quantification of the percentage of
Sox1-positive cells; each dot represents one field of view; n=9, three images each sampled from three biological replicates. (G) qPCR analysis of twoWnt pathway
readouts in Ecad−/− and EcadNcad/Ncad cells during neural differentiation in increasing concentrations ofWnt3a. n=3 biological replicates. For all graphs, error bars
represent s.d., *P≤0.05, **P≤0.01, ***P≤0.001; unpaired Student’s t-test. Scale bars: 50 µm.
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Of 770 genes assayed (Table S4), only a small number were
upregulated in response to N-cadherin. These include markers of early
neuroepithelial cells (Hes5: upregulated 2.4-fold; Pax3:
upregulated 2.3-fold; Jag1: upregulated 1.5-fold,) consistent
with a pro-neural effect of N-cadherin (Table S4). In contrast, a
much larger number of genes (129 out of 142 genes at 48 h post-
induction) were significantly downregulated in response to
N-cadherin overexpression. This suggests that N-cadherin generally
suppresses rather than activates transcriptional responses to signalling
pathways in this context.
We then assigned each of these transcriptional changes to particular
signalling pathways. This revealed that the top three pathways
modulated by N-cadherin are PI3K/Akt, Ras and MAPK; all of these
are pathways downstream of FGF receptors (Fig. 5A). These results
indicated that N-cadherin dampens signalling pathways downstream
of FGF during the early stages of neural differentiation, in keeping
with reports that N-cadherin can interact with the FGF receptor in
other contexts (Greber et al., 2010; Williams et al., 1994, 2001).
N-cadherin promotes neural differentiation by dampening
FGF signalling
We next assessed whether dampening of FGF signalling explains
the pro-neural effect of cadherin switching.
It has previously been reported that FGF signalling promotes the
acquisition and maintenance of primed pluripotency, but must then
be downregulated in order for primed cells to progress to a neural
fate (Greber et al., 2010; Jaeger et al., 2011; Stavridis et al., 2010;
Sterneckert et al., 2010). In keeping with these reports, we found
that blockade of the FGFR1 receptor using 100 ng/ml of the
pharmacological inhibitor PD173074 enhances the efficiency of
neural differentiation when added at D2. Conversely, addition of
20 ng/ml of FGF2 reduces expression of the early neural
markers Sox1 and Pax6 when added at the same time point
(Fig. 5B,C).
Having confirmed that FGF can act as an anti-neural signal in this
context, we set out to test the hypothesis that N-cadherin promotes
neural differentiation by dampening FGF responsiveness. In order
to test this idea, we asked whether boosting FGF activity was able to
reverse the pro-neural effect of N-cadherin.
We used dox-inducible N-cadherin (A2Lox-Ncad-HA) cells in
order to induce N-cadherin overexpression during neural
differentiation. FGF2 or the FGFR1 inhibitor PD173074 were
added in order to modulate FGF activity. We added these reagents at
D2, the same time that dox was added to induce N-cadherin
(Fig. 5B). We used the FGF target genes Etv4 and Dusp4 to monitor
FGF activity and demonstrated that N-cadherin dampens FGF
activity during neural differentiation. We also observed that this
effect could be at least partially rescued by addition of FGF2
(Fig. 5D). We then monitored neural differentiation by measuring
expression of Sox1, Pax6 and Pax3. We found that addition of
FGF2 reversed the pro-neural effects of N-cadherin, restoring the
expression of these genes to similar levels as those seen in control
cells that were undergoing differentiation in the absence of
exogenous FGF or N-cadherin (Fig. 5D).
We conclude that N-cadherin can promote neural differentiation
by dampening FGF signalling.
Fig. 5. Cadherin switching promotes neural differentiation by dampening FGF signalling. (A) Top five signalling pathways most affected by N-cadherin
overexpression 48 post-induction compared with un-induced control. Data generated by DAVID functional annotation of Nanostring mRNA expression values.
142 genes out of 770 genes tested changed significantly. (B) Protocol for FGF modulation experiments in inducible N-cadherin overexpressing cell lines.
(C) qPCR analysis inWT cells with FGF2 or PD173074 (PD17). n=3 biological replicates, error bars represent s.e.m. *P≤0.05, **P≤0.01 compared with untreated
control, unpaired Student’s t-test. (D) qPCR analysis of gene expression after 48 h of N-cadherin induction. n=9, error bars represent s.d., *P≤0.05, ***P≤0.001,
unpaired Student’s t-test. n.s., no significance.
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Cadherin switching and neural differentiation are more
synchronous in vivo than in vitro
N-cadherin is first detectable in a subset of undifferentiated epiblast
stem cells prior to neural differentiation (Fig. 1). Cadherin switching
then proceeds progressively over several days and is not completed
in all cells until after neural fate is established. We next asked
whether cadherin switching also occurs asynchronously over
several days during neural development in vivo.
E-cadherin is expressed throughout the anterior epiblast during
gastrulation. Although we were able to detect N-cadherin protein
in EpiSC, we were unable to detect this adhesion molecule in
the anterior epiblast of mouse embryos during gastrulation.
N-cadherin protein is, however, readily detectable in mesoderm
that has migrated from the posterior to lie adjacent to the
anterior epiblast, as previously reported (Radice et al., 1997)
(Fig. 6A, Fig. S5).
We then focused on the newly formed Sox1+ cells within the
neural plate. We observed that this region uniformly displays
E-cadherin but lacks detectable N-cadherin until after gastrulation
(Fig. 6A, Fig. S5). In contrast to the heterogeneity in cadherin
expression observed before and during neural differentiation in
culture (Fig. 1A,H), wewere unable to detect any obvious local cell-
to-cell variability in expression of either E- or N-cadherin within the
epiblast or the early neuroepithelium (Fig. 6A). We also noticed that
almost every cell expresses Sox1 in the anterior neuroepithelium
in vivo, whereas in contrast only around a third of cells express Sox1
during an equivalent stage of neural differentiation in culture
(Fig. 6B-F).
We conclude that in the embryo, cells acquire N-cadherin after the
acquisition of neural identity, consistent with a role in stabilising rather
than inducing neural fate. We also observe that cadherin switching
occurs relatively synchronously in vivo, in contrast with the
asynchronous acquisition of N-cadherin in culture. Given our finding
that N-cadherin can stabilise neural identity, this dysregulation of
cadherin switching in vitro may help to explain why neural
differentiationproceeds less synchronously in culture than in the embryo.
DISCUSSION
Here, we report that the switch from E- to N-cadherin helps to
reinforce neural commitment by dampening FGF signalling. It has
previously been reported that premature cadherin switching results
in gross morphological and cell-fate allocation defects at
gastrulation, resulting at least in part from defects in extra-
embryonic tissues (Basilicata et al., 2016). Our findings suggest
that there may also be a cell-autonomous requirement for cadherin
switching during neural differentiation.
E-cadherin is required to initiate differentiation in some contexts
(Pieters et al., 2016), but once differentiation is triggered cadherins
Fig. 6. Cadherin switching and neural differentiation are more synchronous in vivo than in vitro. (A) E- and N-cadherin co-expression in an embryonic day
(E)7.5mouse embryo, sagittal view. (B) A region of Sox1+ neuroectoderm adjacent to Sox-negativemesoderm and endoderm is shown from an E7.5 embryo. Nuclei
stained with DAPI. (C) Nuclear segmentation and binning of cells shown in B. Cells are assigned as belonging to the neuroectoderm layer (green) or non-
neurectoderm layers (blue). Unassigned cells are shown in yellow. (D) Sox1 expression at day 3 of neural differentiation in vitro. Nuclei are stained with the nuclear
envelope marker lamin B1. (E) Quantitative analysis of Sox1 expression in neural and non-neural tissues of the anterior E7.5 embryo. n=438 nuclei per sample.
(F) Quantitative analysis of Sox1 expression at day 3 of neural differentiation in vitro, cultured with and without the neural differentiation inhibitor Wnt3a. n=231
nuclei per sample. In E and F, percentages refer to the proportion of Sox1-positive cells in the neural sample (red line; negative control population in black) as
calculated by the non-overlapping area under the two curves. Endo, endoderm; Epi, epiblast; Meso, mesoderm; NE, neuroectoderm. Scale bars: 50 µm.
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can have positive or negative effects on subsequent lineage
specification (Pieters et al., 2016; Takehara et al., 2015),
highlighting the multiple stage-specific effects of cadherins during
differentiation of pluripotent cells. Our experiments focus on neural
differentiation and so our data do not exclude the possibility that
N-cadherin modulates differentiation into other lineages.
Our findings confirm previous reports that the absence of
E-cadherin can limit the pool of nuclear β-catenin (Hendriksen
et al., 2008; Orsulic et al., 1999; Van De Wetering et al., 2001), but
we find that this does not result in a dampening of the transcriptional
response to Wnt in differentiating neural progenitors; this is in
keeping with similar findings in some cell types (Hendriksen et al.,
2008; Orsulic et al., 1999; Van De Wetering et al., 2001), but
contrasts with findings in other contexts where changes in E-cadherin
domodulate the transcriptional response toWnt (Howard et al., 2011;
Libusova et al., 2010). Nevertheless, cadherin switching enables cells
to resist the anti-neural effects of Wnt, possibly through an indirect
mechanism. It would be interesting to explore the positional identity
and potency of the Sox1+ cells that emerge in the presence of
exogenous Wnt and N-cadherin, given that Sox1 is expressed in
neuromesodermal progenitors (Cambray and Wilson, 2007)
and that Wnt helps support neuromesodermal progenitor
identity in the posterior of the embryo (Takemoto et al.,
2005; Turner et al., 2014).
We find that N-cadherin can dampen FGF activity, leading us to
speculate that N-cadherin might contribute to reinforcing neural
commitment by protecting early neural cells from fluctuations in the
anti-neural pro-mesoderm FGF signal. Because N-cadherin on one
cell will stabilise N-cadherin on neighbouring cells through
homotypic interaction, it is tempting to speculate that N-cadherin
helps to propagate this neural-stabilisation effect through the tissue
via a type of ‘community effect’. This could help ensure that neural
commitment proceeds robustly in the embryo. It has recently been
proposed that cadherins propagate mesodermal differentiation from
cell to cell in an in vitro model of the primitive streak, although in
that case communication is propagated predominantly through
changes in E-cadherin rather than N-cadherin (Martyn et al., 2018).
Differentiation is more variable and unpredictable in culture
compared with the embryo, even though the extrinsic signalling
environment in a culture dish can be tightly controlled.We speculate
that a cadherin-mediated community effect may operate less
efficiently in culture where the earliest N-cadherin-positive cells
will often encounter neighbours that lack N-cadherin.
This work highlights the importance of changes in adhesion and
morphology in ensuring robust development, and suggests that
efforts to mimic these changes in culture will be crucial for gaining
full control over differentiation of pluripotent cells.
MATERIALS AND METHODS
Animal care and use
Animal experiments (Mus musculus MF1) were performed under the UK
Home Office project license PEEC9E359, approved by the Animal Welfare
and Ethical Review Panel of the University of Edinburgh and within the
conditions of the Animals (Scientific Procedures) Act 1986. The sex of
embryos used in this study was not determined.
Mouse ESC culture
Naïve stem cell culture (2i-Lif )
Naïve ESCs were maintained in 2i-Lif medium (Ying et al., 2008). This
medium is N2B27 supplemented with 1 µM PD0325901, 3 µM Chiron
99021 and 100 units/ml LIF on laminin-coated tissue culture plates. Naïve
stem cells were derived by passaging LIF-serum-cultured ESCs into 2i-Lif
conditions, and maintaining them for at least three passages.
LIF-serum culture
ESCs were maintained in GMEM supplemented with 2-mercaptoethanol,
non-essential amino acids, glutamine, pyruvate, 10% FCS and 100 units/ml
LIF on gelatinised tissue culture flasks (Smith, 1991).
Epiblast stem cell culture
EpiSCs were maintained under published conditions (Brons et al., 2007;
Tesar et al., 2007). Briefly, the cells were maintained in N2B27 solution
supplemented with 20 ng/ml activin and 10 ng/ml FGF on fibronectin-coated
tissue culture plates. EpiSCs were derived by passaging LIF-serum-cultured
ESCs into EpiSC conditions, and maintaining them for at least three passages.
Cell lines
E14tg2αmouse ESCs were used as WT cells. Previously published cell lines
were generously provided by the researchers and labs who generated them:
Sox1-GFP (‘46C’) cells (Aubert et al., 2003); EcadNcad/Ncad cells (Basilicata
et al., 2016; Kan et al., 2007), which were targeted to an E14.1 background,
and chimeric micewere then backcrossed to C57BL/6 for at least three or four
generations before homozygous EcadNcad/Ncad ESCs were established from
blastocysts; Ecad−/− cells on an E14-IB10 background, inwhich exons 4 to 15
were Cre-excised in vitro (Derksen et al., 2006; Pieters et al., 2016).
To generate dox-inducible N-cadherin overexpressing ESCs, the
inducible cassette exchange (ICE) method was used (Iacovino et al.,
2011, 2014). Primers were designed to allow for the amplification of a DNA
fragment containing the Cdh2 gene C-terminally tagged with an influenza
virus hemagglutinin (HA) tag; the whole construct was flanked by XhoI and
NotI restriction sites. The construct was ligated into a pCR Blunt II Topo
vector (Thermo Fisher Scientific). TheCdh2-HA insert was then ligated into
a p2Lox-eGFP plasmid, replacing an eGFP sequence in this construct
(Iacovino et al., 2009). The resulting p2Lox-Cdh2-HA plasmid was then
nucleofected into A2LoxCre cells. The cells were then cultured for 10 days
under G418 selection, and surviving clonal colonies were then expanded.
Clones were then screened for Ncad and HA expression by
immunocytochemistry (ICC), and three clones with high transgene
expression were selected for use in further experiments.
All cell lines used in this study were tested to confirm the absence of
mycoplama contamination.
Differentiation protocols
Monolayer neural differentiation was performed by passaging 2i-Lif-
cultured ESCs at low density into laminin-coated tissue culture plates. The
cells were maintained in 2i-Lif for 24 h to allow the cells to properly adhere
to the matrix. After 24 h, media were changed to N2B27 medium in which
commercial N2 was replaced with 0.5% modified N2 (made in-house as
described by Pollard et al., 2006). Media were changed every 1-2 days.
qRT-PCR
Primers used for qRT-PCR are described in Table S1. All expression values
were normalised to the geometric mean expression value of at least two of
three housekeeping genes: Tbp, Sdha and Ywhaz.
RPPA analysis
RPPA analysis was performed on nitrocellulose-coated slides as previously
described (Macleod et al., 2017). Briefly, cells were washed with PBS and
lysed in 1% Triton X-100, 50 mM HEPES (pH 7.4), 150 mM sodium
chloride, 1.5 mM magnesium chloride, 1 mM EGTA, 100 mM sodium
fluoride, 10 mM sodium pyrophosphate, 1 mM sodium vanadate, 10%
glycerol, supplemented with cOmplete ULTRA protease inhibitor and
PhosSTOP phosphatase inhibitor cocktails (Roche). Cleared lysates were
serially diluted to produce a four-step doubling dilution series of each
sample, which were spotted in technical triplicate onto nitrocellulose-coated
slides (Grace Bio-Labs) under conditions of constant 70% humidity using
an Aushon 2470 array platform (Aushon Biosystems). After hydration,
slides were blocked using SuperBlock (TBS) blocking buffer (Thermo
Fisher Scientific) and incubated with validated primary antibodies (all
diluted 1:250 in SuperBlock; Table S2). Bound antibodies were detected by
incubation with anti-rabbit DyLight 800-conjugated secondary antibody
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(New England BioLabs). Slides were analysed using an InnoScan 710-IR
scanner (Innopsys), and images were acquired at the highest gain without
saturation of the fluorescence signal. The relative fluorescence intensity of
each array feature was quantified using Mapix software (Innopsys).
Primary antibodies used in this assay are listed in Table S2. In the case of
the Sox1 antibody, we determined that this antibody does not cross-react
with Sox2 based on a lack of signal in undifferentiated ESCs but we cannot
exclude the possibility of cross-reactivity with other Sox family members.
The linear fit of the dilution series of each sample was determined for each
primary antibody, from which median relative fluorescence intensities
(RFI) values were calculated to provide relative quantification of total
protein and phosphoprotein abundance across the sample set. Finally,
signal intensities were normalised to total protein loading for each sample
by using readout from a Fast Green (total protein)-stained array slide.
Enrichment values for EcKO and NcKI cells were normalised to those in
relevant control cell lines, and a mean enrichment was then calculated for
three biological replicates.
Immunofluorescence and FACS
For immunofluorescence analysis, cells cultured on glass coverslips were
fixed in 4% formaldehyde and incubated for at least 30 min in blocking buffer
(PBS, 3% donkey serum and 0.1% Triton X-100). Primary antibodies were
diluted in blocking buffer and applied for 1 h at room temperature or overnight
at 4°C. After three washes in PBS, secondary antibodies conjugated to Alexa
fluorophores (Life Technologies) were diluted at 1:1000 in blocking buffer
and applied for 1 h at room temperature. The cells were washed at least three
times and the coverslips were mounted with Prolong Gold Antifade Reagent
(Life Technologies) on glass slides for viewing.
For antibody staining of live cells for flow cytometry, cells were
incubated with relevant antibodies on ice in the dark for at least 15 min.
Antibodies were diluted in FACS buffer (5% FCS in PBS). Flow cytometric
analysis was performed using a BD Accuri flow cytometer. FACS was
carried out on a FACS Aria cell sorter.
Embryos were fixed with 4% formaldehyde/PBS/0.1% Triton X-100
(Sigma-Aldrich) for 30 min, and quenched with 50 mM ammonium chloride.
Cellular permeabilisation was carried out for 10 min in PBS/0.1% Triton X-
100. The embryos were incubated in primary antibody in 3% donkey serum/
PBS/0.1% Triton X-100 overnight, and subjected to three washes in PBS/
0.1% Triton X-100. Secondary antibodies were applied subsequently for 2 h
to overnight, followed by three washes in PBS/0.1% Triton X-100. Antibody
information is given in Table S3. Embryos were then stained with DAPI
(Biotium), mounted in PBS droplets covered with mineral oil in ‘microscope
rings’, and imaged on a Leica SP8 confocal microscope. Alternatively,
following staining, chimaeric embryos requiring quantification of
immunostaining were dehydrated in methanol series in PBS/0.1% Triton X-
100, clarified in 50% methanol/50% BABB (benzyl alcohol:benzyl benzoate
1:2 ratio, Alfa Aesar and Sigma-Aldrich), transferred into 100% BABB in
glass capillaries and imaged on a Leica SP8 confocal microscope.
Transcript enrichment analysis
Gene enrichment datasets generated by Nanostring were analysed using the
associated NSolver 4.0 software. Functional annotation of gene lists was
performed using the DAVID functional annotation online tool (Huang et al.,
2008, 2009). A list of significantly changing genes was used as an input list,
and all 770 genes tested in the Nanostring analysis (Table S4) were used as a
background list.
Quantitative image analysis
Quantification of membrane-bound protein staining
Where fluorescent signal was to be quantified at the single cell level, cells
were imaged in 3D z-stacks on a Leica SP8 three-detector confocal
microscope. For the quantification of membrane staining, cells were counted
manually using Fiji/ImageJ software.
Quantification of nuclear protein staining
For the quantification of nuclear staining, PickCells softwarewas used. Cells
were segmented by nuclear content or nuclear membrane staining (using
DAPI or the nuclear envelope marker lamin B1 staining, respectively) using
the software’s inbuilt NESSys nuclear segmentation module (Blin et al.,
2019). Protein expression was then quantified as the mean pixel intensity in
any given nucleus. Where staining quality did not allow for accurate nuclear
segmentation, cells were manually designated as either positive or negative
based on a single empirical threshold for all images generated from a single
biological replicate.
Quantification of inter-nuclear edge distances
Inter-nuclear edge distance was calculated using PickCells software in cells
segmented using nuclear membrane staining. The nearest neighbours for
each nucleus were determined using Delaunay triangulation, and the
distance between the membranes of nearest neighbours was calculated for
each nucleus up to a distance of 40 μm.
Statistical analysis
All experiments that were statistically analysed were performed with at least
three independent biological replicates. Statistical significance was
calculated using a paired or unpaired Student’s t-test as appropriate.
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F. and Martinez Arias, A. (2014). Wnt/β-catenin and FGF signalling direct the
specification and maintenance of a neuromesodermal axial progenitor in
ensembles of mouse embryonic stem cells. Development 141, 4243-4253.
doi:10.1242/dev.112979
Utton,M.A., Eickholt, B., Howell, F. V.,Wallis, J. andDoherty, P. (2001). SolubleN-
cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth
and N-cadherin and the fibroblast growth factor receptor co-cluster in cells.
J. Neurochem. 76, 1421-1430. doi:10.1046/j.1471-4159.2001.00140.x
Van De Wetering, M., Barker, N., Harkes, I. C., Van Der Heyden, M., Dijk, N. J.,
Hollestelle, A., Klijn, J. G. M., Clevers, H. and Schultte, M. (2001). Mutant E-
cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer
Res. 61, 278-284.
Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y. and Johnson, K. R.
(2008). Cadherin switching. J. Cell Sci. 121, 727-735. doi:10.1242/jcs.000455
Williams, E. J., Furness, J.,Walsh, F. S. andDoherty, P. (1994). Activation of the FGF
receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin.
Neuron 13, 583-594. doi:10.1016/0896-6273(94)90027-2
Williams, E.-J., Williams, G., Howell, F. V., Skaper, S. D., Walsh, F. S. and
Doherty, P. (2001). Identification of an N-cadherin Motif that can interact with the
fibroblast growth factor receptor and is required for axonal growth. J. Biol. Chem.
276, 43879-43886. doi:10.1074/jbc.M105876200
Wood, H. B. and Episkopou, V. (1999). Comparative expression of the mouse
Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech.
Dev. 86, 197-201. doi:10.1016/S0925-4773(99)00116-1
Ying, Q.-L., Stavridis, M., Griffiths, D., Li, M. and Smith, A. (2003). Conversion of
embryonic stem cells into neuroectodermal precursors in adherent monoculture.
Nat. Biotechnol. 21, 183-186. doi:10.1038/nbt780
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J.,
Cohen, P. and Smith, A. (2008). The ground state of embryonic stem cell self-
renewal. Nature 453, 519-523. doi:10.1038/nature06968
Zhang, J., Woodhead, G. J., Swaminathan, S. K., Noles, S. R., McQuinn, E. R.,
Pisarek, A. J., Stocker, A. M., Mutch, C. A., Funatsu, N. and Chenn, A. (2010).
Cortical neural precursors inhibit their own differentiation via N-cadherin
maintenance of beta-catenin signaling. Dev. Cell 18, 472-479. doi:10.1016/j.
devcel.2009.12.025
13
STEM CELLS AND REGENERATION Development (2019) 146, dev183269. doi:10.1242/dev.183269
D
E
V
E
LO
P
M
E
N
T
Ec
ad
	
	N
ca
d	
La
m
in
B1
	
Ec
ad
	N
ca
d	
	
O
ct
4	
La
m
in
B1
	
Ecad+	
Ncad-	
Oct4+	
Ecad+	
Ncad+	
Oct4+	
Ecad-	
Ncad+	
Oct4+	
Ecad-	
Ncad+	
Oct4-	
Ecad+	
Ncad+	
Oct4-	
Ecad+	
Ncad-	
Oct4-	
Ecad-	
Ncad-	
Oct4-	
Ecad+	
Ncad-	
Sox1+	
Ecad+	
Ncad+	
Sox1+	
Ecad-	
Ncad+	
Sox1+	
Ecad-	
Ncad+	
Sox1-	
Ecad+	
Ncad+	
Sox1-	
Ecad+	
Ncad-	
Sox1-	
Ec
ad
	
	N
ca
d	
La
m
in
B1
	
Ec
ad
	N
ca
d	
So
x1
GF
P	
La
m
in
B1
	
EpiSCs	
Day	4	neural	diﬀerenBaBon	
40.7%	 24.1%	 19.5%	 13.5%	 1.7%	 0.5%	
81.6%	 12.3%	 3.0%	 1.4%	 1.1%	 0.4%	 0.2%	
Figure S1: Single-cell views of protein co-expression in EpiSCs and during neural diﬀerenBaBon.
White	  arrowheads	  point	  out	  individual	  cells	  of	  the	  given	  protein	  expression	  proﬁle. Percentages 
below	 images	 indicate	 the	 propor;on	 of	 cells	 of	 a	 given	 iden;ty	 out	 of	 all	 cells	 analysed 
(manual	quan;ﬁca;on).	Scale	bars=25µm.	A.	EpiSCs	stained	for	E-cadherin	(green),	N-cadherin	(red),	
the	 pluripotency	marker	Oct4	(white)	and	nuclear	envelope	marker	LaminB1	(blue).	N=2596	ce
lls	from	three	 biological	replicates	B.	Cells	on	day	four	of	neural	diﬀeren;a;on	from	a	2i-Lif	s
tar;ng	popula;on	stained	 for	E-cadherin	(green),	N-cadherin	(red),	Sox1-GFP	(shown	in	white), 
and	nuclear	envelope	marker	LaminB1	 (blue).	N=2275	cells	from	three	biological	replicates.		
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neural	diﬀerenBaBon
A:	qPCR	analysis	of	EcadhNcadh/Ncadh	cells		during	successive	days	of	neural	diﬀeren;a;on.	N=3.	Values
normalised	to	control	cell	line	on	D0.	
B:		qPCR	analysis	of	inducible	N-cadherin	overexpressing	cells	during	neural	diﬀeren;a;on;	Dox	added	on	
day	2.	N=9	(three	biological	replicates	of	three	independent	clones).	Values	normalised	to	control	cell	line
on	D0	
Error	bars=SD.	
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Figure	S4:	Eﬀects	of	cadherin	switching	on	β-catenin	and	WNT	signalling.	qPCR	analysis	of	EcadFlox/Flox	an
d	EcadNcad/Ncad	cells	during	neural	diﬀeren;a;on	in	increasing	concentra;ons	of	Wnt3a;	bars	 denote	 mean	 
expression	 rela;ve	 to	 the	 Day	 1	 condi;on	 of	 the	 relevant	 control	 cell	 line	 (grey).	 Asterisks	denote
	signiﬁcant	diﬀerence	compared	to	the	paired	control	cell	line	in	the	same	condi;on.	N=3	biological	 
replicates.	Error	bars=SD,	*p≤0.05,	**p≤0.01,	paired	T-test.		
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Target	gene	 Forward	sequence	 Reverse	sequence	 UPL	probe	number	
Ap2a	 CCGGGTATTAACATCCCAGAT	 CCGAAGAGGTTGTCCTTGTTA	 94	
Axin2	 TGGGGAGCAGTTTTGTGC	 CGGCTGACTCGTTCTCCT	 96	
Cdh1	 ATCCTCGCCCTGCTGATT	 ACCACCGTTCTCCTCCGTA	 18	
Cdh2	 GCCATCATCGCTATCCTTCT	 CCGTTTCATCCATACCACAAA	 18	
Dusp4	 GCCTGGCCTACCTGATGAT	 GCTGCTTGACGAACTCAAAA	 25	
Etv4	 GGGTACCTTGGTGAGCACAG	 CCCTGAGGAGATGTGAAGGA	 66	
Nanog	 CCTCCAGCAGATGCAAGAA	 GCTTGCACTTCATCCTTTGG	 25	
Pax3	 AAAAGGCTAAACACAGCATCG	 CAATATCGGAGCCTTCATCTG	 110	
Pax6	 GTTCCCTGTCCTGTGGACTC	 ACCGCCCTTGGTTAAAGTCT	 78	
Pou3f1	 CTCAAGCCGCTGCTCAAC	 CGCGATCTTGTCCAGGTT	 25	
Pou5f1	 GTTGGAGAAGGTGGAACCAA	 CTCCTTCTGCAGGGCTTTC	 95	
SDHA	 CAGTTCCACCCCACAGGTA	 TCTCCACGACACCCTTCTGT	 71	
Sox1	 GTGACATCTGCCCCCATC	 GAGGCCAGTCTGGTGTCAG	 60	
Sox17	 CACAACGCAGAGCTAAGCAA	 CGCTTCTCTGCCAAGGTC	 97	
T	 ACTGGTCTAGCCTCGGAGTG	 TTGCTCACAGACCAGAGACTG	 27	
TBP	 GGGGAGCTGTGATGTGAAGT	 CCAGGAAATAATTCTGGCTCA	 97	
Ywhaz	 TTACTTGGCCGAGGTTGCT	 TGCTGTGACTGGTCCACAAT	 9	
Table	S1:	qPCR	primer	sequences.		
Primers	used	with	the	Universal	Probe	Library	qPCR	system	from	Roche.	
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Table	S2:	RPPA	anBbodies	
All	an;bodies	were	raised	in	rabbit		
	Epitope		 Supplier Catalogue	no.
Akt Cell	Signaling	Technologies 9272
Akt	P	Ser473 Cell	Signaling	Technologies 4060
Akt	P	Thr308 Cell	Signaling	Technologies 2965
beta-actin Cell	Signaling	Technologies 4970
beta-Catenin Cell	Signaling	Technologies 9562
beta-Catenin	P	Ser33,Ser37,Thr41 Cell	Signaling	Technologies 9561
beta-Catenin	P	Thr41,Ser45 Cell	Signaling	Technologies 9565
Caspase	3 Cell	Signaling	Technologies 9662
Caspase	3	cleaved Cell	Signaling	Technologies 9664
c-Jun	N-term Epitomics 1254-1
c-Jun	P	Ser73 Cell	Signaling	Technologies 9164
E-Cadherin Cell	Signaling	Technologies 3195
GSK-3-alpha/beta	P	Ser21/Ser9 Cell	Signaling	Technologies 9331
GSK-3-beta Cell	Signaling	Technologies 9315
GSK-3-beta	P	Ser9 Cell	Signaling	Technologies 9336
IGF-1R	beta Cell	Signaling	Technologies 3027
ILK1	(4G9) Cell	Signaling	Technologies 3856
Integrin	alpha	4 Cell	Signaling	Technologies 4600
Integrin	Beta	1	[EP1041Y] Abcam ab52971
Integrin	beta3 Cell	Signaling	Technologies 4702
Integrin	beta4 Cell	Signaling	Technologies 4707
IRS-1 Cell	Signaling	Technologies 2382
JAK1 Cell	Signaling	Technologies 3332
JAK1	P	Tyr1022,Thr1023 Invitrogen	(Biosource) 44-422G
MAPKAPK-2 Epitomics 1497-1
MAPKAPK-2	P	Thr334 Cell	Signaling	Technologies 3041
MEK1/2 Cell	Signaling	Technologies 9122
MEK1/2	P	Ser217/221 Cell	Signaling	Technologies 9154
MEK6	[EP558Y] Abcam ab52937
mTOR Cell	Signaling	Technologies 2972
mTOR	P	Ser2448 Cell	Signaling	Technologies 2971
NFkB	p105/p50 Calbiochem GTX110585
NFkB	p65	Ser536 Cell	Signaling	Technologies 3033
p38	MAPK Cell	Signaling	Technologies 9212
p38	MAPK	PThr180,Tyr182 Cell	Signaling	Technologies 9211
p44/42	MAPK	(ERK1/2) Cell	Signaling	Technologies 9102
p44/42	MAPK	(ERK1/2)	P	
Thr202/Thr185,Tyr204/Tyr187
Cell	Signaling	Technologies 4370
p90	S6	kinase	(Rsk1-3) Santa	Cruz sc-231
PDK-1 Cell	Signaling	Technologies 3062
PDK-1	P	Ser241 Cell	Signaling	Technologies 3061
PKA Abcam ab26322
Prohibitin Santa	Cruz sc-28259
Raf	P	Ser338 Cell	Signaling	Technologies 9427
Rsk2	Pser	227 Cell	Signaling	Technologies 3556
Slug	(C19G7 Cell	Signaling	Technologies 9585
Smad1/5	P	Ser463/Ser465 Cell	Signaling	Technologies 9516
Smad2	P	Ser465,Ser467 Cell	Signaling	Technologies 3108
Smad2/3	P	Ser465/Ser423,Ser467/Ser425 Cell	Signaling	Technologies 8828
Smad3	P	Ser423,Ser425 Cell	Signaling	Technologies 9520
Stat3 Cell	Signaling	Technologies 12640
Stat3	P	Y705 Cell	Signaling	Technologies 9131
Stat5 Invitrogen	(Biosource) 44-368G
Stat5	P	Tyr694 Cell	Signaling	Technologies 9351
Stat6 Cell	Signaling	Technologies 9362
Stat6	P	Tyr641 Cell	Signaling	Technologies 9361
Tsc-2	(Tuberin) Cell	Signaling	Technologies 3612
Tsc-2	(Tuberin)	P	Thr1462 Cell	Signaling	Technologies 3617
YAP	P	Ser127 Cell	Signaling	Technologies 4911
YAP1	[EP1674Y] Abcam ab52771
Zyxin Cell	Signaling	Technologies 3553
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Table	S3:	Immunocytochemistry	and	ﬂow	cytometry	an;bodies
All	an;bodies	were	diluted	to	the	speciﬁed	concentra;on	in	blocking	buﬀer.		
	
Epitope	recognised	 Clone	 Host	
species	
Dilution	
factor	
Supplier	 Cat.	
number	
β-catenin	(active),	
dephosphorylated	on	
Ser37	or	Thr41	
8E7	 Mouse	 1:1000	 Millipore	 05-665	
E-cadherin	 DECMA-1	 Rat	 1:200	 Sigma	 U3254	
E-cadherin,	eFluor660-
conjugated	
DECMA-1	 Rat	 1:300	 eBioscience	 50-3249-
82	
GFP	 Polyclonal	 Chicken	 1:1000	 Abcam	 13970	
HA	 HA-7	 Mouse	 1:1000	 Sigma	 H3663	
Laminβ1	 Polyclonal	 Chicken	 1:1000	 Abcam	 Ab90169	
Laminβ1	 Polyclonal	 Rabbit	 1:1000	 Abcam	 Ab16048	
N-cadherin	 32	 Mouse	 1:200	 BD	 610920	
N-cadherin,	AlexaFluor488-
conjugated	
Polyclonal	 Sheep	 1:50	 R&D	 FAB6426G	
Oct4	 N-19	 Goat	 1:200	 Santa	Cruz	 SC-8628	
Sox1	 N23-844	 Mouse	 1:200	 Pharmigen	 560749	
1
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Table S4. Significant changes in gene expression 48 h after N-cadherin 
overexpression during neural differentiation Cells were cultured for 48 h in neural 
differentiation conditions when N-cadherin overexpression was induced by addition 
of Dox. RNA samples were collected for Nanostring gene expression analysis 48 h 
later. The analysis included 770 genes involves in cellular signalling pathways. Values 
show mean enrichment compared to un-induced controls. N=3 biological replicates.
Click here to Download Table S4
